Bipolar I disorder

临床试验

计划入组 34 人 · 首次发布于 2013 年 7 月 4 日

已完成

NCT00177463

L-Carnosine for Bipolar I Disorder

计划入组 47 人 · 首次发布于 2005 年 9 月 15 日

已完成

NCT01986114

A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

计划入组 495 人 · 首次发布于 2013 年 11 月 18 日

药物

查看全部 887 →

Small Molecule

Approved

Lamotrigine(Lamictal)

生产企业：Glaxosmithkline, Aurobindo pharma ltd，另有 18 家

相关疾病：Bipolar 1 Disorder, Generalized Tonic-Clonic Seizures，另有 2 项

C₉H₇Cl₂N₅

Small Molecule

Approved

asenapine(Saphris, Secuado, Sycrest)

相关疾病：Bipolar 1 Disorder, Mixed manic depressive episode，另有 2 项

C₁₇H₁₆ClNO · Rx

Small Molecule

Approved

Lurasidone(Latuda)

相关疾病：Depression, Bipolar, Schizophrenia

C₂₈H₃₆N₄O₂S · Rx

机构

查看全部 118 →

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Universitetet i Oslo

Norway

I-SHOU UNIVERSITY

Taiwan

临床试验

Pilot Study of Cognitive Behavioral Therapy for Anxiety and Bipolar I Disorder

L-Carnosine for Bipolar I Disorder

A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

药物

Lamotrigine(Lamictal)

asenapine(Saphris, Secuado, Sycrest)

Lurasidone(Latuda)

机构

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

Universitetet i Oslo

I-SHOU UNIVERSITY

资讯

FDA Approves Iloperidone (Fanapt®) for Acute Treatment of Bipolar I Disorder

FDA Accepts Review of UZEDY for Bipolar I Disorder Treatment Extension

Vanda Pharmaceuticals Submits NDA for Novel Antipsychotic Bysanti to Treat Bipolar I Disorder and Schizophrenia